4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001062993-23-020921
Director acquired 257,739 shares (grant or award)
- Director acquired 3,303,699 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kalayoglu Murat Director | 2023-11-13 | Grant or award | +257,739 | 257,739 | D: show line 1 in the form | ||
| Kalayoglu Murat Director | 2023-11-13 | Other acquisition | +3,303,699 | 3,303,699 | I: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kalayoglu Murat Director | 2023-11-13 | Grant or award · Series A Non-Voting Convertible Preferred Stock | +14,755.61 | 14,755.61 | D: show line 3 in the form | ||
| Kalayoglu Murat Director | 2023-11-13 | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +189,136.77 | 189,136.77 | I: show line 4 in the form | ||
| Kalayoglu Murat Director | 2023-11-13 | Purchase · Series A Non-Voting Convertible Preferred Stock | +619.63 | $249,999.98 | $154,906,738 | 619.63 | I: show line 5 in the form |
Loading xslF345X05/form4.xml…